Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens. [electronic resource]
Producer: 20130306Description: 1625-34 p. digitalISSN:- 1473-5571
- Acquired Immunodeficiency Syndrome -- drug therapy
- Anti-HIV Agents -- immunology
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Drug Therapy, Combination
- Endoscopy
- Female
- Gastrointestinal Tract -- immunology
- Humans
- Immune Reconstitution Inflammatory Syndrome -- chemically induced
- Immunohistochemistry
- Lymphocyte Activation
- Lymphoid Tissue -- immunology
- Male
- Nevirapine -- therapeutic use
- Nitriles
- Pyridazines -- therapeutic use
- Pyrimidines
- Pyrrolidinones -- therapeutic use
- RNA, Viral
- Raltegravir Potassium
- Reverse Transcriptase Inhibitors -- therapeutic use
- Viral Load
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.